These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37711886)

  • 1. Circulating Proteins and Mortality in CKD: A Proteomics Study of the AASK and ARIC Cohorts.
    Srialluri N; Surapaneni A; Schlosser P; Chen TK; Schmidt IM; Rhee EP; Coresh J; Grams ME
    Kidney Med; 2023 Oct; 5(10):100714. PubMed ID: 37711886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the Circulating Proteome Associated with Albuminuria.
    Kiernan E; Surapaneni A; Zhou L; Schlosser P; Walker KA; Rhee EP; Ballantyne CM; Deo R; Dubin RF; Ganz P; Coresh J; Grams ME
    J Am Soc Nephrol; 2023 Jun; 34(6):1078-1089. PubMed ID: 36890639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine Biomarkers of Kidney Tubule Health and Risk of Incident CKD in Persons Without Diabetes: The ARIC, MESA, and REGARDS Studies.
    Amatruda JG; Katz R; Rebholz CM; Sarnak MJ; Gutierrez OM; Schrauben SJ; Greenberg JH; Coresh J; Cushman M; Waikar S; Parikh CR; Schelling JR; Jogalekar MP; Bonventre JV; Vasan RS; Kimmel PL; Ix JH; Shlipak MG;
    Kidney Med; 2024 Jun; 6(6):100834. PubMed ID: 38826568
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Chen TK; Surapaneni AL; Arking DE; Ballantyne CM; Boerwinkle E; Chen J; Coresh J; Köttgen A; Susztak K; Tin A; Yu B; Grams ME
    Clin J Am Soc Nephrol; 2022 May; 17(5):684-692. PubMed ID: 35474272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Baseline and Longitudinal Serum Uromodulin With Kidney Failure and Mortality: Results From the African American Study of Kidney Disease and Hypertension (AASK) Trial.
    Chen TK; Estrella MM; Appel LJ; Surapaneni AL; Köttgen A; Obeid W; Parikh CR; Grams ME
    Am J Kidney Dis; 2024 Jan; 83(1):71-78. PubMed ID: 37690632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Metabolomic Alterations Associated with Proteinuria in CKD.
    Luo S; Coresh J; Tin A; Rebholz CM; Appel LJ; Chen J; Vasan RS; Anderson AH; Feldman HI; Kimmel PL; Waikar SS; Köttgen A; Evans AM; Levey AS; Inker LA; Sarnak MJ; Grams ME;
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):342-353. PubMed ID: 30733224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated proteomic and metabolomic modules identified as biomarkers of mortality in the Atherosclerosis Risk in Communities study and the African American Study of Kidney Disease and Hypertension.
    Zhou L; Surapaneni A; Rhee EP; Yu B; Boerwinkle E; Coresh J; Grams ME; Schlosser P
    Hum Genomics; 2022 Nov; 16(1):53. PubMed ID: 36329547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study.
    Schneider MP; Schmid M; Nadal J; Krane V; Saritas T; Busch M; Schultheiss UT; Meiselbach H; Friedrich N; Nauck M; Floege J; Kronenberg F; Wanner C; Eckardt KU;
    Kidney Med; 2023 Nov; 5(11):100725. PubMed ID: 37915964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.
    Lane BR; Demirjian S; Derweesh IH; Takagi T; Zhang Z; Velet L; Ercole CE; Fergany AF; Campbell SC
    Eur Urol; 2015 Dec; 68(6):996-1003. PubMed ID: 26012710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study.
    Wen D; Zheng Z; Surapaneni A; Yu B; Zhou L; Zhou W; Xie D; Shou H; Avila-Pacheco J; Kalim S; He J; Hsu CY; Parsa A; Rao P; Sondheimer J; Townsend R; Waikar SS; Rebholz CM; Denburg MR; Kimmel PL; Vasan RS; Clish CB; Coresh J; Feldman HI; Grams ME; Rhee EP;
    JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36048534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of Immune Activation and Incident Kidney Failure With Replacement Therapy: Findings From the African American Study of Kidney Disease and Hypertension.
    Chen TK; Estrella MM; Appel LJ; Coresh J; Luo S; Reiser J; Obeid W; Parikh CR; Grams ME
    Am J Kidney Dis; 2021 Jul; 78(1):75-84.e1. PubMed ID: 33388403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.
    Bash LD; Erlinger TP; Coresh J; Marsh-Manzi J; Folsom AR; Astor BC
    Am J Kidney Dis; 2009 Apr; 53(4):596-605. PubMed ID: 19110358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study.
    Matsushita K; Selvin E; Bash LD; Astor BC; Coresh J
    Am J Kidney Dis; 2010 Apr; 55(4):648-59. PubMed ID: 20189275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteins Associated with Risk of Kidney Function Decline in the General Population.
    Grams ME; Surapaneni A; Chen J; Zhou L; Yu Z; Dutta D; Welling PA; Chatterjee N; Zhang J; Arking DE; Chen TK; Rebholz CM; Yu B; Schlosser P; Rhee EP; Ballantyne CM; Boerwinkle E; Lutsey PL; Mosley T; Feldman HI; Dubin RF; Ganz P; Lee H; Zheng Z; Coresh J
    J Am Soc Nephrol; 2021 Sep; 32(9):2291-2302. PubMed ID: 34465608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testican-2 Is Associated with Reduced Risk of Incident ESKD.
    Wen D; Zhou L; Zheng Z; Surapaneni A; Ballantyne CM; Hoogeveen RC; Shlipak MG; Waikar SS; Vasan RS; Kimmel PL; Dubin RF; Deo R; Feldman HI; Ganz P; Coresh J; Grams ME; Rhee EP;
    J Am Soc Nephrol; 2023 Jan; 34(1):122-131. PubMed ID: 36288905
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Luo S; Surapaneni A; Zheng Z; Rhee EP; Coresh J; Hung AM; Nadkarni GN; Yu B; Boerwinkle E; Tin A; Arking DE; Steinbrenner I; Schlosser P; Köttgen A; Grams ME
    Clin J Am Soc Nephrol; 2020 Dec; 16(1):37-47. PubMed ID: 33380473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression.
    Tin A; Nadkarni G; Evans AM; Winkler CA; Bottinger E; Rebholz CM; Sarnak MJ; Inker LA; Levey AS; Lipkowitz MS; Appel LJ; Arking DE; Coresh J; Grams ME
    J Am Soc Nephrol; 2018 Jul; 29(7):1939-1947. PubMed ID: 29777021
    [No Abstract]   [Full Text] [Related]  

  • 19. Protein Biomarkers and Major Cardiovascular Events in Older People With Advanced CKD: The European Quality (EQUAL) Study.
    Hayward SJL; Chesnaye NC; Hole B; Aylward R; Meuleman Y; Torino C; Porto G; Szymczak M; Drechsler C; Dekker FW; Evans M; Jager KJ; Wanner C; Caskey FJ;
    Kidney Med; 2024 Jan; 6(1):100745. PubMed ID: 38162538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study.
    Sika M; Lewis J; Douglas J; Erlinger T; Dowie D; Lipkowitz M; Lash J; Cornish-Zirker D; Peterson G; Toto R; Kusek J; Appel L; Kendrick C; Gassman J;
    Am J Kidney Dis; 2007 Jul; 50(1):78-89, 89.e1. PubMed ID: 17591527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.